Developed by Shray Alag, The Harker School
Sections: Correlations,
Clinical Trials, and HPO
Navigate: Clinical Trials and HPO
Navigate: Correlations HPO
There is one clinical trial.
The disease caused by SARS-CoV-2, has derived a pandemic in which its evolution and complications depend on the immune capacity of the host. The virus has been characterized by presenting an inflammatory cascade, increased by the overproduction of proinflammatory cytokines, the decrease in metalloenzymes and also the rapid spread of the virus. There are several lines of treatment, however, nutritional treatment only considered a caloric intake. For this reason, this study will evaluate the evolution of patients with COVID-19 assisted by nutritional support based on supplements such as omega 3, zinc, selenium, vitamin D, glutamine, prebiotics, and foods such as spirulina and the effect of this therapy in reducing complications and comorbidities. Research question: Will the nutritional support system reduce complications in stage III positive COVID-19 patients with comorbidities (type 2 DM, SAH, overweight / obesity with BMI <35), with a better benefit than that achieved with the conventional nutritional treatment ?. Hypothesis: The nutritional support system will reduce the complications of patients with COVID-19 in stage III with comorbidities. General Objective: To determine the effect of the use of a nutritional support system on complications in patients with COVID-19 in stage III with comorbidities. Methodology: A controlled, blinded, randomized clinical trial will be conducted in patients with COVID-19, hospitalized at the ISSEMYM Toluca Arturo Montiel Rojas Medical Center, who meet the inclusion criteria. The evolution of the group of patients receiving the nutritional support system (NSS) and the normal diet implemented by the hospital will be evaluated against the group of patients receiving only the diet, using laboratory and cabinet tests during their hospital stay. Statistical analysis: for independent groups with normal distribution, Student's T will be applied. If the distribution does not meet normality criteria, a Mann Whitney U will be performed; Two-way ANOVA will be applied to monitor the groups over time with normal distribution. If the distribution does not meet normality criteria, a Friedman test will be performed, in both cases post hoc tests will be performed. The results will be analyzed using version 8 of the Graphpad Prism software.
Description: Fraction of oxygen-saturated hemoglobin relative to the patient's total blood hemoglobin, represented as a percentage. Measurement using the pulse oximeter of the multi-parameter vital signs monitor. Measurement units % SpO2.
Measure: Oxygen saturation Time: 1 minuteDescription: Balance between the production of heat by the body and its loss. Measurement using an infrared thermometer. Units of measure degrees centigrade.
Measure: Body temperature Time: 30 secondsDescription: Force exerted by the blood against the walls of the vessels (arteries) as it is pumped by the heart. Measurement using the multi-parameter vital signs monitor. Units of measurement in mmHg. Obtain systolic and diastolic pressure.
Measure: Blood pressure Time: 2 minutesDescription: Number of times the heart beats for a certain period of time, measured by the multi-parameter vital signs monitor. Units of measure beats per minute.
Measure: Heart rate Time: 1 minuteDescription: Number of breaths that a living being takes during a certain period of time, Count daily with the patient at rest the number of breaths for one minute each time the chest rises. Measured in breaths per minute.
Measure: Breathing frequency Time: 1 minuteDescription: Disruption of the organic functions of any living being. The existence of the death certificate will be reviewed daily. Categories: dead or alive.
Measure: Death Time: 10 secondsDescription: Simultaneous knowledge, in the unity of time, of oneself (subject) and of the surrounding world (object), is the reflection of reality. It will be evaluated daily with the glasgow scale. Categories: 1.13-15 points. 2. 9-12 points. 3. 3-8 points.
Measure: Awareness Time: 2 minutesDescription: Number of days that the patient remains hospitalized. It is reviewed daily if the patient has been discharged. Categories: 1.Hopitalized. 2. Released.
Measure: Hospital stay Time: 10 secondsDescription: Rapid sequential evaluation of organic failures. Evaluate daily the qSOFA items and get your score. Measure in points.
Measure: qSOFA score Time: 1 minuteDescription: Clinically and study-based acquired need to open the airway in order to supply him with oxygen. Check daily if a cannula or tube was placed in the windpipe. Categories: 1.Progress to ventilation. 2. Does not progress to ventilation.
Measure: Progression to ventilation Time: 10 secondsDescription: Need for a multidisciplinary team, for presenting an acute critical state, with the support of technological resources for monitoring, diagnosis and treatment. It is reviewed daily if the patient is directed to ICU. Categories: 1.Enter ICU. 2. You do not enter ICU.
Measure: Progression to Intensive Care Unit Time: 10 secondsDescription: Any localized painful discomfort in the head. Evaluate and ask for pain by numbering it from 1-10, where 0 is the absence and 10 is the greatest intensity (Daily, 2 shifts, 21 days).
Measure: Cephalea Time: 10 secondsDescription: Physical actions that you can take without pain or discomfort. Evaluate what movements and activities he tolerates (Daily, 2 shifts, 21 days). Categories: 1.Walk. 2.He can stand 3.Sit. 4.Postrate.
Measure: Activity level Time: 10 secondsDescription: Body postures that are used to facilitate the examination of the patient, his treatment, the prevention of injuries due to immobility, and his comfort when he is bedridden. Observe the anatomical position in which he is found (Daily, 2 shifts, 21 days). Categories: 1. In the prone position. 2.In the supine position. 3.Fowler. 4.Semifowler. 5.Other
Measure: Anatomic position Time: 10 secondsDescription: Evaluate the level of hydration of the hair (Daily, morning, 21 days). Categories: 1.Hydrated, shiny. 2.Opaque. 3.Very dull and dry.
Measure: Hair hydration Time: 19 secondsDescription: Evaluate hair loss with the "pull sign" by pulling the hair without the intention of plucking, daily in the morning (Daily, morning, 21 days).Categories 1. <5 hairs on hand. 2. 5-10 hairs. 3.> 10 hairs.
Measure: Hair loss Time: 20 secondsDescription: Targeted search for one or more asymptomatic sudden onset decalvary patches throughout the hair territory (Daily, morning, 21 days). Categories: 1. Without decalvary plates. 2. With regional decalvary plates. 3. Generalized alopecia areata.
Measure: Decalvary patches Time: 10 secondsDescription: Inspect the scalp for lesions (Daily, morning, 21 days). Categories: 1.No injuries. 2. Flaking. 3.Erythema. 4.Infection. 5. Bleeding.
Measure: Scalp lesions Time: 15 secondsDescription: Ask about itching of the scalp (Daily, morning, 21 days). Categories: 1.Without itching. 2.Itching.
Measure: Itching scalp Time: 10 secondsDescription: Evaluate the absence or loss of eyelashes, daily in the morning. Categories: 1.Without alterations. 2.White spaces. 3. Fall when exploring.
Measure: Loss of eyelashes Time: 15 secondsDescription: Evaluate the absence or drooping of eyebrows (Daily, morning, 21 days). Categories: 1. Without alterations. 2.White spaces. 3. Fall when exploring.
Measure: Drooping of eyebrows Time: 10 secondsDescription: Evaluate eyelid edema (Daily, morning, 21 days). Categories: 1. Without edema. 2. With edema
Measure: Eyelid edema Time: 5 secondsDescription: Check the vascularity of the sclera (Daily, morning, 21 days). Categories: 1.White sclera. 2.Small blood vessels. 3. Large blood vessels. 4.Hemorrhage.
Measure: Vascularity of the sclera Time: 10 secondsDescription: Assess ocular hydration (Daily, morning, 21 days). Categories: 1.Hydrated. 2.Dry mucus. 3.Absence of tears. 4 sunken eyes
Measure: Ocular hydration Time: 15 secondsDescription: Evaluate sclera color, daily in the morning. Categories: 1.White. 2. Localized yellow. 3.General yellow. 4.Other colors.
Measure: Sclera color Time: 10 secondsDescription: Evaluation of smell, presenting non-irritating odors and ask if it distinguishes them (Daily, morning, 21 days). Categories: 1.Normal. 2. Hyposmia. 3.Anosmia.
Measure: Sense of smell Time: 30 secondsDescription: Evaluate the presence of irritation in the nostrils (Daily, morning, 21 days). Categories: 1.No irritation. 2.With irritation.
Measure: Irritation in the nostrils Time: 10 secondsDescription: Assess nasal secretions (Daily, morning, 21 days). Categories: 1. Absence. 2.Transparent. 3.Of other colors. 4.With blood.
Measure: Nasal secretions Time: 10 secondsDescription: Evaluate the presence of cheilitis (Daily, morning, 21 days). Categories: 1.Without cheilitis. 2.Unilateral. 3.Bilateral. 4.With ulcers.
Measure: Cheilitis Time: 5 secondsDescription: Assess taste buds (Daily, morning, 21 days). Categories: 1. Normal. 2. Inflamed. 3. Painful. 4. Bleeding.
Measure: Taste buds Time: 10 secondsDescription: Evaluate the presence of the saw edge of the tongue (Daily, morning, 21 days). Categories 1.Normal. 2.Flat 3.With serrated edge.
Measure: Saw edge of the tongue Time: 10 secondsDescription: Look for changes in the body of the tongue (Daily, morning, 21 days). Categories: 1.No alterations. 2.Geographic. 3.Fissured.
Measure: Changes in the body of the tongue Time: 10 secondsDescription: Look for changes in the thickness of the tongue (Daily, morning, 21 days). Categories: 1. Normal thickness. 2. Abnormal thickness, swollen.
Measure: Thickness of the tongue Time: 5 secondsDescription: Assess the presence of salivation (Daily, morning, 21 days). Categories: 1.Normal. 2.Excessive salivation. 3 absent.
Measure: Salivation Time: 10 secondsDescription: Evaluate the taste presenting food from their tray and ask if you distinguish the flavors (Daily, morning, 21 days). Categories: 1.Conserved. 2. Hypogeusia. 3.Ageusia.
Measure: Taste Time: 30 secondsDescription: Evaluation of the gums (Daily, morning, 21 days). Categories: 1.Normal. 2.Hypersensitive 3.Inflamed. 4. Bleeding.
Measure: Gums Time: 10 secondsDescription: Evaluation of skin sensitivity (Daily, morning, 21 days). Categories: 1.Normal. 3.Altered sensitivity. 3.Painful.
Measure: Skin sensitivity Time: 30 secondsDescription: Assess the presence of lesions (Daily, morning, 21 days). Categories: 1. No lesions. 2.Dermatitis. 3. Open lesions.
Measure: Skin lesions Time: 10 secondsDescription: Assess skin hydration (Daily, morning, 21 days). Categories: 1.Normal. 2.Fat. 3.Dry.
Measure: Skin hydration Time: 10 secondsDescription: Evaluate skin texture (Daily, morning, 21 days). Categories: 1.Lisa. 2.Rugose. 3.Descamative
Measure: Skin texture Time: 10 secondsDescription: Check for loss or absence of body hair (Daily, morning, 21 days). Categories: 1.Present. 2.Fall. 3.Absence.
Measure: Absence of body hair Time: 10 secondsDescription: Evaluate by finger pressure the 7th cervical hypersensitivity (Every 2 days, morning, 21 days). Categories: 1. It does not cause pain. 2. It causes pain.
Measure: Cervical pain points Time: 5 secondsDescription: Search for hypersensitivity on the inside of the forearm (Every 2 days, morning, 21 days)
Measure: Forearm pain points Time: 5 secondsDescription: Ask if he presents odynophagia (Daily, 2 shifts, 21 days). Categories: 1.Absent. 2. Present.
Measure: Odynophagia Time: 5 secondsDescription: Evaluation of the presence of cough (Daily, 2 shifts, 21 days). Categories: 1.Absent. 2.Productive. 3.Dry
Measure: Cough Time: 5 seconds.Description: Evaluation of the presence of sneezing (Daily, 2 shifts, 21 days). Categories: 1. Absent. 2. Present.
Measure: Sneezing Time: 5 secondsDescription: Respiration rhythm evaluation (Daily, 2 shifts, 21 days). Categories: 1. Normal. 2.Altered.
Measure: Respiration rhythm Time: 1 minuteDescription: Assessment of abdominal breathing (Daily, 2 shifts, 21 days). Categories: 1.Absent. 2. Present.
Measure: Abdominal breathing Time: 20 secondsDescription: Evaluation of the use of accessory muscles when breathing (Daily, 2 shifts, 21 days). Categories: 1.Absent. 2. Present.
Measure: Use of accessory muscles when breathing Time: 10 secondsDescription: Evaluate the presence of xiphoid retraction when breathing (Daily, 2 shifts, 21 days). Categories: 1. Absent. 2. Present.
Measure: Xiphoid retraction when breathing Time: 10 secondsDescription: Assess the presence and degree of dyspnea (Daily, 2 shifts, 21 days). Categories: 1.Without difficulty. 2.When standing. 3.When sitting. 2.When speaking, 3.Lying down.
Measure: Dyspnea Time: 10 secondsDescription: Evaluate the abdomino-cutaneous reflexes (Diary, verpertino, 21 days). Categories: 1. Present. 2. Absent
Measure: Abdomino-cutaneous reflexes Time: 20 secondsDescription: Assess rebound sensitivity (Daily, verpertino, 21 days). Categories: 1. Without sensitivity. 2. With sensitivity.
Measure: Rebound sensitivity Time: 15 secondsDescription: Evaluate the presence of pain in the right hypochondrium. (Daily, evening, 21 days) Categories: 1. No pain. 2. With pain.
Measure: Right hypochondrium Time: 5 secondsDescription: Evaluate the presence of pain in the epigastrium. (Daily, evening, 21 days) Categories: 1. No pain. 2. With pain.
Measure: Epigastrium Time: 5 secondsDescription: Evaluate the presence of pain in the left hypochondrium. (Daily, evening, 21 days) Categories: 1. No pain. 2. With pain.
Measure: Left hypochondrium Time: 5 secondsDescription: Assess the presence of pain in the right flank. (Daily, evening, 21 days) Categories: 1. No pain. 2. With pain.
Measure: Right flank Time: 5 secondsDescription: Assess the presence of pain in the mesogastrium (Daily, evening, 21 days) Categories: 1. No pain. 2. With pain.
Measure: Mesogastrium Time: 5 secondsDescription: Evaluate the presence of pain in the left flank. (Daily, evening, 21 days) Categories: 1. No pain. 2. With pain.
Measure: Left flank Time: 5 secondsDescription: Evaluate the presence of pain in the right iliac fossa. (Daily, evening, 21 days) Categories: 1. No pain. 2. With pain.
Measure: Right iliac fossa. Time: 5 secondsDescription: Evaluate the presence of pain in the hypogastrium. (Daily, evening, 21 days) Categories: 1. No pain. 2. With pain.
Measure: Hypogastrium Time: 5 secondsDescription: Assess the presence of pain in the left iliac fossa. (Daily, evening, 21 days) Categories: 1. No pain. 2. With pain.
Measure: Left iliac fossa. Time: 5 secondsDescription: Ask for the presence of vomiting in 24 hours (Daily, evening, 21 days). Categories: 1. Absent. 2. Present.
Measure: Vomiting Time: 5 secondsDescription: Ask about the presence of appetite (Daily, evening, 21 days). Categories: 1. Increased appetite. 2.Normal 3.Hypoexia. 4.Anorexia.
Measure: Appetite Time: 5 secondsDescription: Ask about the presence of reflux (Daily, evening 21 days). Categories: 1. Absent. 2. After eating (specify food). 3. At bedtime. 4. Sudden
Measure: Reflux Time: 5 secondsDescription: Ask about the presence of more common burps than normal (Daily, evening, 21 days). Categories: 1.Normales 2. Augmented.
Measure: Burps Time: 5 secondsDescription: Evaluation of defecation by means of bowel movements with the Bristol scale (Daily, evening, 21 days). Categories: 1.Normal (T3, T4) 2.Constipation (T1, T2). 3. Diarrhea (T5, T6, T7).
Measure: Bristol scale Time: 10 secondsDescription: Evaluation of hair loss on legs (Every 2 days, evening, 21 days) Categories: 1. Without alterations. 2.White spaces. 3. Fall when exploring.
Measure: Hair loss on legs Time: 10 secondsDescription: Evaluation of the sensitivity of the tibial tract (Every 2 days, evening, 21 days) Categories: 1. No pain. 2.Painful.
Measure: Sensitivity of the tibial tract Time: 10 secondsDescription: Assessment of nail strength (Every 2 days, evening, 21 days). Categories: 1. Strong. 2. Brittle. 3.Not assessable.
Measure: Nail strength Time: 10 secondsDescription: Check the presence of fungus in the nails of the hands (Every 2 days, evening, 21 days). Categories: 1. Absent. 2. Present. 3.Not assessable.
Measure: Fungus in the nails of the hands Time: 10 secondsDescription: Look for the presence of white stripes on the nails (Every 2 days, evening, 21 days). Categories: 1. Absent. 2. Present. 3.Not assessable.
Measure: White stripes on the nails Time: 5 secondsDescription: Look for the presence of white spots on the nails (Every 2 days, evening, 21 days). Categories: 1. Absent. 2. Present. 3.Not assessable.
Measure: White spots on the nails Time: 5 secondsDescription: Look for the presence of ridges on the nails (Every 2 days, evening, 21 days). Categories: 1.Lisas. 2.With ridges. 3.Not assessable.
Measure: Ridges on the nails Time: 5 secondsDescription: Taking the height (at the beginning of the protocol). Measure in cm.
Measure: Height Time: 1 minuteDescription: Weight taking (Every 2 days, 2 hours after breakfast, for 21 days). Measured in kg.
Measure: Weight Time: 1 minuteDescription: Calculation of BMI (Every 2 days, morning, for 21 days). Measured in kg / m2.
Measure: BMI Time: 30 secondsDescription: Measurement by blood sample of erythrocytes (Every 3 days, for 21 days). Measured at 10 ^ 6 / uL.
Measure: Erythrocytes Time: 20 secondsDescription: Measurement by blood sample of hemoglobin (Every 3 days, for 21 days). Measured in g / dL.
Measure: Hemoglobin Time: 20 secondsDescription: Measurement by blood sample of hematocrit (Every 3 days, for 21 days). Measurement in %.
Measure: Hematocrit Time: 20 secondsDescription: Measurement by blood sample of mean corpuscular volume (MCV) (Every 3 days, for 21 days). Measured in fL.
Measure: Mean corpuscular volume Time: 20 secondsDescription: Measurement by blood sample of mean hemoglobin concentration (Every 3 days, for 21 days). Measurement in pg.
Measure: Mean hemoglobin concentration Time: 20 secondsDescription: Measurement every 3 days by blood sample of mean corpuscular hemoglobin concentration (Every 3 days, for 21 days). Measured in g / dL
Measure: Mean corpuscular hemoglobin concentration Time: 20 secondsDescription: Erythrocyte distribution width measurement by blood sample (Every 3 days, for 21 days). Measured in%.
Measure: Erythrocyte distribution width Time: 20 secondsDescription: Measurement by blood sample of the hemoglobin distribution index (Every 3 days, for 21 days). Measured in g / dL.
Measure: Hemoglobin distribution index Time: 20 secondsDescription: Measurement by blood sample of leukocytes (Every 3 days, for 21 days). Measured in 10 ^ 3 / μL
Measure: Leukocytes Time: 20 secondsDescription: Measurement by blood sample of neutrophils (%) (Every 3 days, for 21 days). Measurement in%
Measure: Neutrophils (%) Time: 20 secondsDescription: Measurement by blood sample of neutrophils (#) (Every 3 days, for 21 days). Measured in 10 ^ 3 / μL
Measure: Neutrophils (#) Time: 20 secondsDescription: Measurement by blood sample of lymphocytes (%) (Every 3 days, for 21 days). Measurement in%
Measure: Lymphocytes (%) Time: 20 secondsDescription: Measurement by blood sample of lymphocytes (#) (Every 3 days, for 21 days). Measured in 10 ^ 3 / μL
Measure: Lymphocytes (#) Time: 20 secondsDescription: Measurement by blood sample of monocytes (%) (Every 3 days, for 21 days). Measurement in%
Measure: Monocytes (%) Time: 20 secondsDescription: Measurement by blood sample of monocytes (#) (Every 3 days, for 21 days). Measured in 10 ^ 3 / μL
Measure: Monocytes (#) Time: 20 secondsDescription: Measurement by blood sample of eosinophils (%) (Every 3 days, for 21 days). Measurement in%
Measure: Eosinophils (%) Time: 20 secondsDescription: Measurement by blood sample of eosinophils (#) (Every 3 days, for 21 days). Measured in 10 ^ 3 / μL
Measure: Eosinophils (#) Time: 20 secondsDescription: Measurement by blood sample of basophils (%) (Every 3 days, for 21 days). Measurement in%
Measure: Basophils (%) Time: 20 secondsDescription: Measurement by blood sample of basophils (#) (Every 3 days, for 21 days). Measured in 10 ^ 3 / μL
Measure: Basophils (#) Time: 20 secondsDescription: Measurement of prothrombin time (PT) by blood sample (Every 3 days, for 21 days). Measure in seconds
Measure: Prothrombin time Time: 20 secondsDescription: Measurement by blood sample of INR (Every 3 days, for 21 days). Measure in units
Measure: INR Time: 20 secondsDescription: Measurement by control blood sample (100-50) (Every 3 days, for 21 days). Measure in seconds
Measure: Control blood sample (100-50) 1 Time: 20 secondsDescription: Measurement by blood sample of partial thromboplastin time (Every 3 days, for 21 days). Measure in seconds
Measure: Partial thromboplastin time Time: 20 secondsDescription: Measurement by control blood sample (100-50) (Every 3 days, for 21 days). Measure in seconds
Measure: Control blood sample (100-50) 2 Time: 20 secondsDescription: Measurement by blood sample of platelets. Measured in 10 ^ 3 / μL
Measure: Platelets Time: 20 secondsDescription: Measurement by blood sample of mean platelet volume (MPV) (Every 3 days, for 21 days). Measured in fL.
Measure: Mean platelet volume Time: 20 secondsDescription: Initial screening test to diagnose patients with signs or symptoms suggestive of venous thromboembolism, it is a marker of endogenous fibrinolysis. Measurement by blood sample of dimer D (Every 3 days, for 21 days). Measured in ng / mL
Measure: D-dimer Time: 20 secondsDescription: Sulfur amino acid that originates in the metabolism of methionine, and is very aggressive for the arterial endothelium. Measurement by blood sample of homocysteine levels (Every 3 days, for 21 days). Measured in µmol / l.
Measure: Homocysteine Time: 20 secondsDescription: Fat-soluble vitamin involved in calcium homeostasis and bone metabolism, regulation of genes involved in the regulation of cell proliferation, cell differentiation and apoptosis. It has been suggested that it exerts immunomodulatory and antiproliferative effects. Measurement by blood sample of levels of 25-hydroxycholecalciferol (Every 3 days, for 21 days). Measured in nmol / L
Measure: Vitamin D Time: 20 secondsDescription: Measurement by blood sample of calcium (Every 3 days, for 21 days). Measured in mg / dL.
Measure: Calcium Time: 20 secondsDescription: Measurement by blood sample of phosphorus (Every 3 days, for 21 days). Measured in mg / dL.
Measure: Phosphorus Time: 20 secondsDescription: Measurement by blood sample of magnesium (Every 3 days, for 21 days). Measured in mg / dL.
Measure: Magnesium Time: 20 secondsDescription: Measurement by blood sample of sodium (Every 3 days, for 21 days). Measured in mmol / L.
Measure: Sodium Time: 20 secondsDescription: Measurement by blood sample of potassium (Every 3 days, for 21 days). Measured in mmol / L.
Measure: Potassium Time: 20 secondsDescription: Measurement by blood sample of chlorine (Every 3 days, for 21 days). Measured in mmol / L.
Measure: Chlorine Time: 20 secondsDescription: A measure of the concentration of free glucose in the blood, serum or blood plasma. Measured in mg / dL.
Measure: Blood glucose Time: 20 secondsDescription: Taking a blood sample of total cholesterol (Every 3 days, for 21 days). Measured in mg / dL.
Measure: Total cholesterol Time: 20 secondsDescription: Taking a blood sample of triglycerides (Every 3 days, for 21 days). Measured in mg / dL.
Measure: Triglycerides Time: 20 secondsDescription: Taking a blood sample of LDL cholesterol (Every 3 days, for 21 days). Measured in mg / dL.
Measure: LDL cholesterol Time: 20 secondsDescription: Taking a blood sample for HDL cholesterol (Every 3 days, for 21 days). Measured in mg / dL.
Measure: HDL cholesterol Time: 20 secondsDescription: Taking a blood sample to evaluate the level of aspartate aminotransferase (Every 3 days, for 21 days). Measured in U / L.
Measure: Aspartate aminotransferase Time: 20 secondsDescription: Taking a blood sample to evaluate the level of alanine aminotransferase (Every 3 days, for 21 days). Measured in U / L.
Measure: Alanine aminotransferase Time: 20 secondsDescription: Taking a blood sample to evaluate the total bilirubin level (Every 3 days, for 21 days). Measured in mg / dL.
Measure: Total bilirubin Time: 20 secondsDescription: Taking a blood sample to evaluate the level of direct bilirubin (Every 3 days, for 21 days). Measured in mg / dL.
Measure: Direct bilirubin Time: 20 secondsDescription: Taking a blood sample to evaluate the level of indirect bilirubin (Every 3 days, for 21 days). Measured in mg / dL.
Measure: Indirect bilirubin Time: 20 secondsDescription: Taking a blood sample to evaluate the level of alkaline phosphatase (Every 3 days, for 21 days). Measured in U / L.
Measure: Alkaline phosphatase Time: 20 secondsDescription: Taking a blood sample to evaluate the level of total proteins (Every 3 days, for 21 days). Measured in g / dL.
Measure: Total proteins Time: 20 secondsDescription: Taking a blood sample to evaluate the albumin level (Every 3 days, for 21 days). Measured in g / dL.
Measure: Albumin level Time: 20 secondsDescription: Taking a blood sample to evaluate the globulin level (Every 3 days, for 21 days). Measured in g / dL.
Measure: Globulin level Time: 20 secondsDescription: Taking a blood sample to evaluate the A / G ratio (Every 3 days, for 21 days). Measured in g / dL.
Measure: A / G ratio Time: 20 secondsDescription: ake a blood sample to evaluate the levels of urea nitrogen (Every 3 days, for 21 days). Measured in mg / dL.
Measure: Urea nitrogen Time: 20 secondsDescription: Take a blood sample to evaluate urea levels (Every 3 days, for 21 days). Measured in mg / dL.
Measure: Urea Time: 20 secondsDescription: Take a blood sample to evaluate creatitine levels (Every 3 days, for 21 days). Measured in mg / dL.
Measure: Creatitine Time: 20 secondsDescription: Take a blood sample to evaluate uric acid levels (Every 3 days, for 21 days). Measured in mg / dL.
Measure: Uric acid Time: 20 secondsDescription: Take a blood sample to evaluate ferritin levels (Every 3 days, for 21 days). Measured in ng/mL.
Measure: Ferritin Time: 20 secondsDescription: Take a blood sample to evaluate fibrinogen levels (Every 3 days, for 21 days). Measured in mg / dL.
Measure: Fibrinogen Time: 20 secondsDescription: Take a blood sample to evaluate the levels of C-reactive protein (Every 3 days, for 21 days). Measured in mg/L.
Measure: C-reactive protein Time: 20 secondsDescription: Use of the appropriate procedures established in the NSS indications (Specific supplementation scheme, based on 1 sachet, intramuscular B vitamins and probiotics). Quantification of empty supplement envelopes (Daily, 2 shifts, 21 days). Categories: 1.On empty. 2. About half. 3.Full.
Measure: Adherence to the Nutritional Support System (NSS) Time: 5 secondsDescription: Quantification of the time from when the envelope is added in water, until everything is consumed (Daily, 2 shifts, 21 days). Categories: 1. Less than 15 minutes. 2. More than 15 minutes.
Measure: Intake time Time: 15 minutesDescription: Quantification of the amount of prepared "NSS" he drink (Daily, 2 shifts, 21 days). Categories: 1.All the preparation. 2.Half. 3.Nothing.
Measure: Amount of prepared "NSS" he drink Time: 15 minutesDescription: In-person verification of the taking of the floratil pill and observe that they do not vomit it (Daily, 2 shifts, first 6 days). Categories: 1. The pill is taken. 2.The pill is not taken.
Measure: Taking of the "floratil" pill Time: 20 secondsDescription: Corroborate in person the correct application of the neurobion injection (Daily, evening, first 5 days). Categories: 1. It applies. 2.Not applicable.
Measure: Neurobion injection Time: 1 minuteDescription: Unit of thermal energy, which is equal to the amount of heat needed to raise the temperature of 1 gram of water by 1 degree Celsius. Unit of measurement of the energy content of food that consists of the number of calories that a given weight of food can develop in the tissues, or in the physical work equivalent to them. Calculate the grams that the food has of each macronutrient and multiply it by the energy intake. Based on the Mexican Equivalent Food System. Number in Kcal.
Measure: Diet calories Time: 15 minutesDescription: Evaluate the amount of trans fat in the diet. (Daily, 2 shifts, 21 days). Based on the Mexican Equivalent Food System. Number in g.
Measure: Trans fat in the diet Time: 2 minutesDescription: Evaluate the amount of saturated fat in the diet. (Daily, 2 shifts, 21 days). Based on the Mexican Equivalent Food System. Number in g.
Measure: Saturated fat in the diet. Time: 2 minutesDescription: Evaluate the amount of monounsaturated fats in the diet. (Daily, 2 shifts, 21 days). Based on the Mexican Equivalent Food System. Number in g.
Measure: Monounsaturated fats in the diet Time: 2 minutesDescription: Evaluate the amount of polyunsaturated fat in the diet. (Daily, 2 shifts, 21 days). Based on the Mexican Equivalent Food System. Number in g.
Measure: Polyunsaturated fat in the diet Time: 2 minutesDescription: Evaluate the amount of protein of animal origin in the diet. (Daily, 2 shifts, 21 days). Based on the Mexican Equivalent Food System. Number in g.
Measure: Protein of animal origin in the diet Time: 2 minutesDescription: Evaluate the amount of plant-based protein in the diet. (Daily, 2 shifts, 21 days). Based on the Mexican Equivalent Food System. Number in g.
Measure: Plant-based protein in the diet Time: 2 minutesDescription: Accurate record of the amount of fluids administered. Evaluate the income of 24 hrs. (Daily, 2 shifts, 21 days). Number in ml.
Measure: Fluid balance (income) Time: 5 minutesDescription: Accurate record of the amount of liquids eliminated by any means. Evaluate the expenses of 24 hrs. (Daily, 2 shifts, 21 days). Number in ml.
Measure: Fluid balance (outcome) Time: 5 minutesDescription: Need or desire to eat. Observe the percentage of the tray with food that was ingested (Daily, 2 shifts, 21 days). Categories: 1. 100% ingested. 2.75%. 3.50%. 4.25%.
Measure: Hungry Time: 15 secondsDescription: Cardiovascular disease risk indicator. Measure with a tape measure with the patient standing, feet together, arms at the sides and the abdomen relaxed, encircling the abdomen at the level of the navel at the midpoint between the last rib and the iliac crest and without pressing, taking an inspiration deep, taking the measurement at the moment of expelling the air.
Measure: Abdominal circumference Time: 1 minuteDescription: It is used to know the nutritional status of the patient. It is obtained by measuring the middle part of the arm with a tape measure, taking as a reference the length between the point of the shoulder (acromion) and the head of the radius (olecranon). Take the circumference of the arm using a tape measure (every 2 days, 2 hours after breakfast, in the morning, for 21 days). Measure in mm.
Measure: Arm circumference. Time: 3 minutesDescription: It is measured on the midline of the back of the arm (triceps) at 1 cm from the height of the midpoint of the arm. Taking triceps fold measuring tape and caliper (every 2 days, 2 hours after breakfast, morning, for 21 days)). Measure in mm.
Measure: Tricipital fold Time: 3 minutesDescription: Calculation from arm circumference and triceps fold. Calculate it according to the formula proposed by Frisancho. (every 2 days, 2 hours after breakfast, morning, for 21 days). Measure in mm2.
Measure: Arm area Time: 1 minuteDescription: Set of peculiarities that characterize the individuals of a species, dividing them into male and female, and make possible a reproduction characterized by genetic diversification. Based on an official ID. Categories: 1. Male 2. Female
Measure: Biological sex Time: 30 secondsDescription: Time elapsed from the birth of a living being to the moment the calculation is made. Based on an official ID. Number between 30 and 75.
Measure: Age Time: 30 secondsDescription: Sugars attached to the surface of red blood cells, and according to their composition. Evaluate by blood sample. Categories: 1.A, 2. B, 3.AB 4.O.
Measure: AB0 system Time: 2 minutesDescription: Protein in red blood cells or erythrocytes. Obtaining by blood sample. Categories: 1.Rh (+) 2.Rh (-).
Measure: Rh factor Time: 2 minutesDescription: Record the use of proton pump inhibitors (omeprazole, pantoprazole) (daily, evening, for 21 days). Categories: 1.Not prescribed. 2.Prescribed.
Measure: Use of proton pump inhibitors Time: 5 secondsDescription: Record the use of obesity medications (orlistat, acarbose, bile acid sequestrants, etc.) (daily, evening, for 21 days). Categories: 1.Not prescribed. 2.Prescribed.
Measure: Obesity medications Time: 5 secondsDescription: Record the use of antiepileptic drugs (daily, evening, for 21 days). Categories: 1.Not prescribed. 2.Prescribed.
Measure: Use of antiepileptic drugs Time: 5 secondsDescription: Record the use of oral contraceptives (daily, evening, for 21 days). Categories: 1.Not prescribed. 2.Prescribed.
Measure: Use of oral contraceptives Time: 5 secondsDescription: Record the use of antimitotics (colchicine) (daily, evening, for 21 days). Categories: 1.Not prescribed. 2.Prescribed.
Measure: Use of antimitotics Time: 5 secondsDescription: Chemical substance that kills or prevents the growth of certain classes of sensitive microorganisms. Record the antibiotics that are being administered. (daily, evening, for 21 days) Categories: 1.Not used. 2.Use of antibiotics (specify which)
Measure: Antibiotics Time: 5 secondsDescription: Medicines whose main pharmacological effect is to relieve pain. Record the analgesics that are being administered (daily, evening, for 21 days). Categories: 1.Not used. 2.Use of analgesics (specify which)
Measure: Analgesics Time: 5 secondsDescription: Drugs with anti-inflammatory and immunosuppressive effect. Record the corticosteroids that are being administered (daily, evening, for 21 days). Categories: 1.Not used. 2.Use of corticosteroids (specify which).
Measure: Corticosteroids Time: 5 secondsDescription: Substance that causes the elimination of water and electrolytes from the body through urine. Record the diuretics that are being administered (daily, evening, for 21 days). Categories: 1.Not used. 2.Use of diuretics (specify which)
Measure: Diuretics Time: 5 secondsDescription: Drugs used to lower blood pressure. Record the antihypertensive drugs that are being administered (daily, evening, for 21 days). Categories: 1.Not used. 2.Use of antihypertensives (specify which)
Measure: Antihypertensive Time: 5 secondsDescription: Endogenous or exogenous substance that interferes with or inhibits blood clotting, creating an antithrombotic or prohemorrhagic state. Record the anticoagulants that are being administered (daily, evening, for 21 days). Categories: 1.Not used. 2.Use of anticoagulants (specify which)
Measure: Anticoagulants Time: 5 secondsDescription: Medications that attend to a basic pathology and have not been considered in the previous variables. Record the medications that are being administered and have not been named before (daily, evening, for 21 days). Write the medications.
Measure: Other medications Time: 5 secondsDescription: Disturbance of the normal state of the level of absorption acutely due to a pathological alteration. Record the acute alterations that affect the absorption of nutrients (daily, evening, for 21 days). Categories: 1.None. 2.Intolerance. 3. Allergies 4. Diarrhea 5. Infection or inflammation in any organ of the digestive system.
Measure: Acute alterations in the absorption of nutrients. Time: 5 secondsDescription: Any alteration in the response to the action of the drug due to the concomitant reaction of another chemical substance. Side effects reported through the clinic and laboratory (daily, evening, for 21 days). Categories: 1.None. 2.Rash. 3.Head or dizziness. 4.Gastrointestinal pain. 5.Other (specify).
Measure: Drug interactions and adverse effects Time: 5 secondsDescription: Artificial supply of oxygen (O2) in the inspired air; its main objective is tissue oxygenation. Check the quantity of liters that you have pre-written for 24 hours (daily, evening, for 21 days). Number of liters.
Measure: Oxygen therapy Time: 5 secondsDescription: Attitude or disposition in emotional life. It is not a transitory emotional situation. It is a state, a way of staying, of being, whose duration is prolonged and fades over the rest of the psychic world. Assess the patient's state of mind (daily, evening, for 21 days). Categories: 1.Happy. 2.Relaxed. 3. Alert. 4. Annoying 5. Sad. 6.Tense. 7.Tired. 8.Depressed
Measure: Mood Time: 5 secondsAlphabetical listing of all HPO terms. Navigate: Correlations Clinical Trials
Data processed on September 26, 2020.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.
Drug Reports MeSH Reports HPO Reports